Automated insulin delivery was improved with improved glycemic control metrics among patients with type 2 diabetes regardless of C-peptide levels.
Recent evidence reveals that more patients could benefit from receiving a continuous glucose monitoring prescription as part of diabetes care from their primary provider.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback